Mainstay Medical receives €30 million funding from investors
Category: #health  By Saipriya Iyer  Date: 2018-02-16
  • share
  • Twitter
  • Facebook
  • LinkedIn

Mainstay Medical receives €30 million funding from investors

Mainstay Medical International plc, a firm that manufactures medical implantable device ReActiv8 ®, has raised funds worth approximately €30.1 million. Reportedly, the firm has raised this funding through issuing nearly 2,151,332 ordinary shares to its current and new stakeholders. Some of the company’s key officials have stated that the funds will be utilized to fulfill myriad business goals including the finalization of the U.S. ReActive8-B clinical trials, which supports the medical application for PMA (pre-market approval) from food & drug authority of the U.S.

According to Business Insider, a major  portion of the gross proceeds will be utilized for promotional  and commercializing activities of  ReActiv8 across European countries such as Germany and other potential markets along with its launch in the U.S. healthcare market.

Reliable sources claim that the ReActive8-B Study will be completely finalized by the second quarter of 2018 with the total number of patients in the clinical trials speculated to be more than 168. Investors of this financing round apparently include financial institutions of Europe and North America, that received new share each at a price of €14. Reports also claim that the ISIF (Ireland Strategic Investment Fund), an Ireland based sovereign development fund investing in commercial activities for creating employment & promoting economic activities in the country, is anticipated to purchase nearly 33% of new shares, the value of which is estimated at nearly €10 million.

Industry analysts believe that Mainstay is trying to expand its operations in Ireland after receiving ISIF fundings. They are of the opinion that the firm will also benefit from the strong talent pool available in Ireland. The Directors of the medical device firm believe that the investments will help in the business expansion of the firm while simultaneously aiding the company to reach more customers and enhance the overall job creation across the Irish industry.



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

Foodics enters Egypt market by setting an on-ground presence in Cairo
Foodics enters Egypt market by setting an on-ground presence in Cairo
By Saipriya Iyer

Saudi Arabia-based restaurant management platform Foodics, has announced that it has entered the Egyptian market by creating an on-the-ground presence in Cairo.  The expansion comes after the company raised USD 4 ...

Food Emulsifiers Market to Witness an Appreciable Growth By 2026
Food Emulsifiers Market to Witness an Appreciable Growth By 2026
By Saipriya Iyer

This advanced report on the Food Emulsifiers Market includes of an in-depth overview of this business sphere. Alongside, details of the present market size and status have been given. The report aims to provide substantial updates on the market, p...

Bharat Biotech reveals positive data from animal trial of Covaxin
Bharat Biotech reveals positive data from animal trial of Covaxin
By Saipriya Iyer

Bharat Biotech, an Indian biotechnology company, has reportedly revealed positive results from the animal trial of Covaxin, India’s COVID-19 vaccine candidate.

In the animal t...